Are machines jumping on Johnson & Johnson's human risk headlines?
Shares continue to fall on Monday after Friday's swift descent.
Many analysts advise buying the shares on weakness because it's attractively priced.
The market appears to still be spooked by JNJ as shares are set to open at their lowest level since July amid the Reuters articles fallout.
This reliable name should continue to generate consistent income, no matter what the stock market does.
The market is ripe for stock picking and Real Money is here to help you off of the sidelines.
The company's move to reduce the overall use of antibiotics marks another step in its shift towards more natural food sourcing.
Analysts and experts have begun to warm to the modernization plan that CEO Easterbrook has slated to reinvigorate MCD into the coming years.
Analysts say the old standby could end up as a market leader based on its historical resilience in tough markets and its aggressive remodeling efforts.
Kraft Heinz and DowDuPont spinoff Chemours offer attractive dividends and value potential.